glp 1 announcement today PRESS The first GLP-1 pill for the treatment of obesity is now approved by the US Food and Drug Administration (FDA). Learn more in our company here: https://t.co/w9RVHx6Suy CMS Expands Access to GLP-1
Description
Ozempic and other GLP-1 receptor agonists have rapidly become some of the most talked-about medications in the management of type 2 diabetes and weight-relat...
Data are presented as medians (interquartile ranges) or frequencies (%), and Wilcoxon signed-rank tests and Mann-Whitney U tests were used for paired and nonpaired group comparisons, respectively
Recent Findings Retatrutide is the first triple agonist (acting on GLP-1/GIP/glucagon receptors) with published phase 2 data in people with obesity as well as in people with T2D
The only live Akkermansia probiotic clinically shown to fortify the gut lining, reduce gut permeability, and support gut health
gut barrier function
4-Slot 3ml Vial Storage Case Compact Organizer for GLP-1, Insulin & Peptide Supplies
